Darwin C. Dornbush is Director at CANTEL MEDICAL CORP (CMN). They have made 5 open-market trades across 2 companies since 2006, most recently 2016-12-15.
CIK 0001244403
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CMN | SELL | 2006-07-21 | 2006-07-25 | $14.65 | $49K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2006-04-21 | 2006-04-25 | $14.58 | $16K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2006-03-24 | 2006-03-27 | $16.30 | $41K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2006-03-17 | 2006-03-21 | $16.27 | $122K | -7.1% | -3.4% | -3.4% |
| BNHN | SELL | 2006-02-07 | 2006-06-16 | $25.29 | $1.6M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.